Abecma

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 59572-515
  • Package NDC 59572-515-01
  • Package NDC 59572-515-02
  • Package NDC 59572-515-03
  • Application number BLA125736
  • SPL ID 4adbd9af-42bb-4e51-86fc-b06ccd213b43
  • SPL set ID b90c1fe7-f5cc-464e-958a-af36e9c26d7c
  • UNII 8PX1X7UG4D
  • RxCUI 2536434
  • RxCUI 2536439
  • RxCUI 2536443
  • RxCUI 2536445
  • RxCUI 2536449
  • RxCUI 2536451

What the source publishes

Labeler
Celgene Corporation
Active ingredients
idecabtagene vicleucel
Form
SUSPENSION
Routes
INTRAVENOUS
Administrative status
present-in-source-snapshot
Marketing status
BLA
Product type
CELLULAR THERAPY

Names this record is found by

Complete source data
us:fda:ndc:59572-515_4adbd9af-42bb-4e51-86fc-b06ccd213b43
{
  "name": "Abecma",
  "splId": "4adbd9af-42bb-4e51-86fc-b06ccd213b43",
  "labels": [
    {
      "setId": "b90c1fe7-f5cc-464e-958a-af36e9c26d7c",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b90c1fe7-f5cc-464e-958a-af36e9c26d7c",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b90c1fe7-f5cc-464e-958a-af36e9c26d7c"
    }
  ],
  "routes": [
    "INTRAVENOUS"
  ],
  "labeler": "Celgene Corporation",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "1 SUSPENSION in 1 BAG (59572-515-01)",
      "package_ndc": "59572-515-01",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20210326"
    },
    {
      "sample": false,
      "description": "1 SUSPENSION in 1 BAG (59572-515-02)",
      "package_ndc": "59572-515-02",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20210326"
    },
    {
      "sample": false,
      "description": "1 SUSPENSION in 1 BAG (59572-515-03)",
      "package_ndc": "59572-515-03",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20210326"
    }
  ],
  "productId": "59572-515_4adbd9af-42bb-4e51-86fc-b06ccd213b43",
  "useDomain": "unknown",
  "dosageForm": "SUSPENSION",
  "productNdc": "59572-515",
  "deaSchedule": null,
  "genericName": "idecabtagene vicleucel",
  "productType": "CELLULAR THERAPY",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "IDECABTAGENE VICLEUCEL",
      "strength": "300000000 1/1"
    }
  ],
  "applicationNumber": "BLA125736",
  "marketingCategory": "BLA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20210326",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "unknown",
  "harmonizedIdentifiers": {
    "unii": [
      "8PX1X7UG4D"
    ],
    "rxcui": [
      "2536434",
      "2536439",
      "2536443",
      "2536445",
      "2536449",
      "2536451"
    ],
    "spl_set_id": [
      "b90c1fe7-f5cc-464e-958a-af36e9c26d7c"
    ],
    "manufacturer_name": [
      "Celgene Corporation"
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:59572-515_4adbd9af-42bb-4e51-86fc-b06ccd213b43"